Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance

Journal of Lipid Research

Volumn 52, Issue 6, 2011, Pages 1234-1246

  Han, Myoung Sook ^a   Lim, Yu Mi ^a   Quan, Wenying ^a   Kim, Jung Ran ^b   Chung, Kun Wook ^a   Kang, Mira ^a   Kim, Sunshin ^c   Park, Sun Young ^a   Han, Joong Soo ^d   Park, Shin Young ^d   Cheon, Hyae Gyeong ^b   Rhee, Sang Dal ^e   Park, Tae Sik ^b   Lee, Myung Shik ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Gachon University College of Medicine   (South Korea)

^c National Cancer Center   (South Korea)

^d Hanyang University   (South Korea)

^e Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Diabetes; Lipids; Muscle; Obesity; Phospholipase A2

Indexed keywords

BROMOENOL LACTONE; CERAMIDE; DIACYLGLYCEROL; G PROTEIN COUPLED RECEPTOR; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN RECEPTOR SUBSTRATE 1; LYSOPHOSPHATIDYLCHOLINE; OLEIC ACID; PALMITIC ACID; PALMITOYL TRIFLUOROMETHYL KETONE; PERTUSSIS TOXIN; PHOSPHOLIPASE A2 INHIBITOR; SATURATED FATTY ACID; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; LIPID LIVER LEVEL; LIVER PARENCHYMA; MOUSE; MUSCLE LEVEL; MUSCLE TISSUE; MYOTUBE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD PROTEINS; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GENE SILENCING; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; LYSOPHOSPHATIDYLCHOLINES; MICE; MICE, KNOCKOUT; MUSCLE FIBERS, SKELETAL; NAPHTHALENES; PALMITIC ACID; PERTUSSIS TOXIN; PHOSPHOLIPASES A2, CALCIUM-INDEPENDENT; PHOSPHORYLATION; PYRONES; RECEPTORS, G-PROTEIN-COUPLED; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 79956017931     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M014787     Document Type: Article

References (54)

1. Reaven, G. M., C. Hollenbeck, C. Y. Jeng, M. S. Wu, and Y. D. Chen. 1988. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes. 37: 1020-1024.
2. Roden, M., T. B. Price, G. Perseghin, K. F. Petersen, D. L. Rothman, G. W. Cline, and G. I. Shulman. 1996. Mechanism of free fatty acid-induced insulin resistance in humans. J. Clin. Invest. 97: 2859-2865.
3. Zhou, Y. P., and V. E. Grill. 1994. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J. Clin. Invest. 93: 870-876.
4. Shimabukuro, M., M. Y. Wang, Y. T. Zhou, C. B. Newgard, and R. H. Unger. 1998. Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression. Proc. Natl. Acad. Sci. USA. 95: 9558-9561.
5. Holland, W. L., J. T. Brozinick, L. P. Wang, E. D. Hawkins, K. M. Sargent, Y. Liu, K. Narra, K. L. Hoehn, T. A. Knotts, A. Siesky, et al. 2007. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab. 5: 167-179.
6. Koves, T. R., J. R. Ussher, R. C. Noland, D. Slentz, M. Mosedale, O. Ilkayeva, J. Bain, R. Stevens, J. R. Dyck, C. B. Newgard, et al. 2008. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7: 45-56.
7. Montell, E., M. Turini, M. Marotta, M. Roberts, V. Noe, C. J. Ciudad, K. Mace, and A. M. Gomez-Foix. 2001. DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells. Am. J. Physiol. 280: E229-E237.
8. Perseghin, G., P. Scifo, F. De Cobelli, E. Pagliato, A. Battezzati, C. Arcelloni, A. Vanzulli, G. Testolin, G. Pozza, A. del Maschio, et al. 1999. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans. Diabetes. 48: 1600-1606.
9. Han, M. S., S. Y. Park, K. Shinzawa, S. Kim, K. W. Chung, J. H. Lee, C. H. Kwon, K. W. Lee, J-H. Lee, C. K. Park, et al. 2008. Lysophosphatidylcholine as a death effector in lipoapoptosis of hepatocytes. J. Lipid Res. 49: 84-97.
10. Niu, W., C. Huang, Z. Nawaz, M. Levy, R. Somwar, D. Li, P. J. Bilan, and A. Klip. 2003. Maturation of the regulation of GLUT4 activity by p38 MAPK during L6 cell myogenesis. J. Biol. Chem. 278: 17953-17962.
11. Cnop, M., J. C. Hannaert, A. Hoorens, D. L. Elizirik, and D. G. Pipeleers. 2001. Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes. 50: 1771-1777.
12. Pacheco, Y. M., M. C. Pérez-Camino, A. Cert, E. Montero, and V. Ruiz-Gutiérrez. 1998. Determination of the molecular species composition of diacylglycerols in human adipose tissue by solid-phase extraction and gas chromatography on a polar phase. J. Chromatogr. B Biomed. Sci. Appl. 714: 127-132.
13. Yu, C., Y. Chen, G. W. Cline, D. Zhang, H. Zong, Y. Wang, R. Bergeron, J. K. Kim, S. W. Cushman, G. J. Cooney, et al. 2002. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277: 50230-50236.
14. Yoo, H. H., J. Son, and D-H. Kim. 2006. Liquid chromatographytandem mass spectrometric determination of ceramides and related lipid species in cellular extracts. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 843: 327-333.
15. Han, M. S., K. W. Chung, H. G. Cheon, S. D. Rhee, C. H. Yoon, M. K. Lee, K. W. Kim, and M. S. Lee. 2009. Imatinib mesylate reduces endoplasmic reticulum stress and induces remission of diabetes in db/db mice. Diabetes. 58: 329-336.
16. Kozma, L., K. Baltensperger, J. Klarlund, A. Porras, E. Santos, and M. P. Czech. 1993. The ras signaling pathway mimics insulin action on glucose transporter translocation. Proc. Natl. Acad. Sci. USA. 90: 4460-4464.
17. Kaku, K., F. T. Fiedorek, M. Province, and A. Permutt. 1988. Genetic analysis of glucose tolerance in inbred mouse strains-evidence for polygenic control. Diabetes. 37: 707-713. (Pubitemid 19043176)
18. Cai, D., M. Yuan, D. F. Frantz, P. A. Melendez, L. Hansen, J. Lee, and S. E. Shoelson. 2005. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11: 183-190.
19. Hirosumi, J., G. Tuncman, L. Chang, C. Z. Gorgun, K. T. Uysal, K. Maeda, M. Karin, and G. S. Hotamisligil. 2002. A central role for JNK in obesity and insulin resistance. Nature. 420: 333-336.
20. Solinas, G., W. Naugler, F. Galimi, M-S. Lee, and M. Karin. 2006. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc. Natl. Acad. Sci. USA. 103: 16454-16459.
21. Lee, Y. H., J. Giraud, R. J. Davis, and M. F. White. 2003. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J. Biol. Chem. 278: 2896-2902.
22. Merril, A. H., Jr., G. van Echten, E. Wang, and K. Sandhoff. 1993. Fumonisin B1 inhibits sphingosin (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. J. Biol. Chem. 268: 27299-27306.
23. Tonnetti, L., M. C. Veri, E. Bonvini, and L. D'Adamio. 1999. A role for neutral sphingomyelinase-mediated ceramide production in T cell receptor-induced apoptosis and mitogen-activated protein kinase-mediated signal transduction. J. Exp. Med. 189: 1581-1589.
24. Chalfant, C. E., B. Ogretmen, S. Galadari, B-J. Kroesen, B. J. Pettus, and Y. A. Hannun. 2001. FAS activation induces dephosphorylation of SR proteins. J. Biol. Chem. 276: 44848-44855.
25. Ogretmen, B., B. J. Pettus, M. J. Rossi, R. Wood, J. Usta, Z. Szulc, A. Bielawska, L. M. Obeid, and Y. A. Hannun. 2002. Biochemical mechanisms of the generation of endogenous long chain ceramide in response to exogenous short chain ceramide in the A549 human lung adenocarcinoma cell line. J. Biol. Chem. 277: 12960-12969.
26. Fang, X., S. Gibson, M. Flowers, T. Furui, R. C. Bast, Jr., and G. B. Mills. 1997. Lysophosphatidylcholine stimulates activator protein 1 and the c-Jun N-terminal kinase activity. J. Biol. Chem. 272: 13683-13689.
27. Motley, E. D., S. M. Kabir, C. D. Gardner, K. Eguchi, G. D. Frank, T. Kuroki, M. Ohba, T. Yamakawa, and S. Eguchi. 2002. Lysophosphatidylcholine inhibits insulin-induced Akt activation through protein kinase C-alpha in vascular smooth muscle cells. Hypertension. 39: 508-512. (Pubitemid 34165174)
28. Balsinde, J., and E. A. Dennis. 1996. Bromoenol lactone inhibits magnesium-dependent phosphatidate phosphohydrolase and blocks triacylglycerol biosynthesis in mouse P388D1 macrophages. J. Biol. Chem. 271: 31937-31941.
29. Ostrander, D. B., G. C. Sparagna, A. A. Amoscato, J. B. McMillin, and W. Dowhan. 2001. Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis. J. Biol. Chem. 276: 38061-38067.
30. Kabarowski, J. H. S., K. Zhu, L. Q. Le, O. N. Witte, and Y. Xu. 2001. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science. 293: 702-705. (Pubitemid 32728673)
31. Zhu, K., L. B. Baudhuin, G. Hong, F. S. Williams, K. L. Cristina, J. H. S. Kabarowski, O. N. Witte, and Y. Xu. 2001. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J. Biol. Chem. 276: 41325-41335.
32. Hama, K., J. Aoki, M. Fukaya, Y. Kishi, T. Sakai, R. Suzuki, H. Ohta, T. Yamori, M. Watanabe, J. Chun, et al. 2004. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and nonneoplastic cells through LPA1. J. Biol. Chem. 279: 17634-17639.
33. Phillips, D. I., P. M. Clark, C. N. Hales, and C. Osmond. 1993. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet. Med. 11: 286-292.
34. Nakamura, S., T. Takamura, N. Matsuzawa-Nagata, H. Takayama, H. Misu, H. Noda, S. Nabemoto, S. Kurita, T. Ota, H. Ando, et al. 2009. Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria. J. Biol. Chem. 284: 14809-14818.
35. Itoh, Y., Y. Kawamata, M. Harada, M. Kobayashi, R. Fujii, S. Fukusumi, K. Ogi, M. Hosoya, Y. Tanaka, H. Uejima, et al. 2003. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature. 422: 173-176. (Pubitemid 36362750)
36. Avignon, A., K. Yamada, X. Zhou, B. Spencer, O. Cardona, S. Saba- Siddique, L. Galloway, M. L. Standaert, and R. V. Farese. 1996. Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goto-Kakizaki (GK), obese/aged, and obese/Zucker rats. A mechanism for inhibiting glycogen synthesis. Diabetes. 45: 1396-1404.
37. Krssak, M., P. K. Falk, A. Dresner, L. DiPietro, S. M. Vogel, D. L. Rothman, M. Roden, and G. I. Shulman. 1999. Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1HNMR spectroscopy study. Diabetologia. 42: 113-116.
38. Pan, D. A., S. Lillioja, A. D. Krisketos, M. R. Milner, L. A. Baur, C. Bogardus, A. B. Jenkins, and L. H. Storlien. 1997. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes. 46: 983-988.
39. Listenberger, L. L., X. Han, S. E. Lewis, S. Cases, R. V. Farese, D. S. Ory, and J. E. Schaffer. 2003. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl. Acad. Sci. USA. 100: 3077-3082.
40. Eitel, K., H. Staiger, J. Rieger, H. Mischak, H. Brandhorst, M. D. Brendel, R. G. Bretzel, H. U. Haring, and M. Kellerer. 2003. Protein kinase C delta activation and translocation to the nucleus are required for fatty acid-induced apoptosis of insulin-secreting cells. Diabetes. 52: 991-997. (Pubitemid 36384269)
41. Takahashi, M., H. Okazaki, Y. Ogata, K. Takeuchi, U. Ikeda, and K. Shimada. 2002. Lysophosphatidylcholine induces apoptosis in human endothelial cells through a p38-mitogen-activated protein kinase-dependent mechanism. Atherosclerosis. 161: 387-394. (Pubitemid 34219192)
42. Coll, T., E. Eyre, R. Rodriguez-Calvo, X. Palomer, R. M. Sanchez, M. Merlos, J. C. Laguna, and M. Vazquez-Carrera. 2008. Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells. J. Biol. Chem. 283: 11107-11116.
43. Schmitz-Peiffer, C., D. L. Craig, and T. J. Biden. 1999. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J. Biol. Chem. 274: 24202-24210.
44. Hanada, K. 2003. Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochim. Biophys. Acta. 1632: 16-30.
45. Song, M. J., K. H. Kim, J. M. Yoon, and J. B. Kim. 2006. Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem. Biophys. Res. Commun. 346: 739-745.
46. Jove, M., A. Planavila, J. C. Laguna, and M. Vazquez-Carrera. 2005. Palmitate-induced interleukin 6 production is mediated by protein kinase C and nuclear-factor kappaB activation and leads to glucose transporter 4 down-regulation in skeletal muscle cells. Endocrinology. 146: 3087-3095. (Pubitemid 41002818)
47. Jove, M., A. Planavila, R. M. Sanchez, M. Merlos, J. C. Laguna, and M. Vazquez-Carrera. 2006. Palmitate induces tumor necrosis factoralpha expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-kappaB activation. Endocrinology. 147: 552-561. (Pubitemid 43004310)
48. van den Besselaar, A. M., B. de Kruijff, H. van den Bosch, and L. L. van Deenen. 1979. Transverse distribution and movement of lysophosphatidylcholine in sarcoplasmic reticulum membranes as determined by 13C NMR and lysophospholipase. Biochim. Biophys. Acta. 555: 193-199.
49. Xie, Y., T. C. Gibbs, and K. E. Meier. 2002. Lysophosphatidic acid as an autocrine and paracrine mediator. Biochim. Biophys. Acta. 1582: 270-281.
50. Bao, S., H. Song, M. Wohltmann, S. Ramanadham, W. Jin, A. Bohrer, and J. Turk. 2006. Insulin secretory responses and phospholipid composition of pancreatic islets from mice that do not express group VIA phospholipase A2 and effects of metabolic stress on glucose homeostasis. J. Biol. Chem. 281: 20958-20973.
51. Mancuso, D. J., H. F. Sims, K. Yang, M. A. Kiebish, X. Su, C. M. Jenkins, S. Guan, S. H. Moon, T. Pietka, F. Nassir, et al. 2010. Genetic ablation of calcium-independent phospholipase A2gamma prevents obesity and insulin resistance during high fat feeding by mitochondrial uncoupling and increased adipocyte fatty acid oxidation. J. Biol. Chem. 285: 36495-36510.
52. Song, H., M. Wohltmann, S. Bao, J. H. Ladenson, C. F. Semenkovich, and J. Turk. 2010. Mice deficient in group VIB phospholipase A2 (iPLA2gamma) exhibit relative resistance to obesity and metabolic abnormalities induced by a Western diet. Am. J. Physiol. Endocrinol. Metab. 298: E1097-E1114.
53. Shinzawa, K., and Y. Tsujimoto. 2003. PLA2 activity is required for nuclear shrinkage in caspase-independent cell death. J. Cell Biol. 163: 1219-1230. (Pubitemid 38032084)
54. Cauwels, A., B. Janssen, A. Waeytens, C. Cuvelier, and P. Brouckaert. 2003. Caspase inhibition causes hyperacute tumor necrosis factorinduced shock via oxidative stress and phospholipase A2. Nat. Immunol. 4: 387-393.